相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combination of fluvastatin with pegylated interferon/ribavirin therapy reduces viral relapse in chronic hepatitis C infected with HCV genotype 1b
Masanori Atsukawa et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Dclk1 distinguishes between tumor and normal stem cells in the intestine
Yuki Nakanishi et al.
NATURE GENETICS (2013)
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
Ludmila Prokunina-Olsson et al.
NATURE GENETICS (2013)
miR-122 regulates hepatic lipid metabolism and tumor suppression
Jessica Wen et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver
Shu-hao Hsu et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis
Wei-Chih Tsai et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Explaining statin inhibition effectiveness of HMG-CoA reductase by quantum biochemistry computations
Roner F. da Costa et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2012)
Targeting tumor cell metabolism with statins
J. W. Clendening et al.
ONCOGENE (2012)
Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex
Tetsuro Shimakami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Productive Hepatitis C Virus Infection of Stem Cell-Derived Hepatocytes Reveals a Critical Transition to Viral Permissiveness during Differentiation
Xianfang Wu et al.
PLOS PATHOGENS (2012)
DCAMKL-1 Regulates Epithelial-Mesenchymal Transition in Human Pancreatic Cells through a miR-200a-Dependent Mechanism
Sripathi M. Sureban et al.
CANCER RESEARCH (2011)
New HCV therapies on the horizon
J. Vermehren et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Effects of Hypolipidemic Agent Nordihydroguaiaretic Acid on Lipid Droplets and Hepatitis C Virus
Gulam H. Syed et al.
HEPATOLOGY (2011)
Hepatitis C Virus-Induced Cancer Stem Cell-Like Signatures in Cell Culture and Murine Tumor Xenografts
Naushad Ali et al.
JOURNAL OF VIROLOGY (2011)
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Assembly of infectious hepatitis C virus particles
Ralf Bartenschlager et al.
TRENDS IN MICROBIOLOGY (2011)
Statin Therapy and Serum Transaminases Among a Cohort of HCV-Infected Veterans
Louise M. Henderson et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Serum Cholesterol and Statin Use Predict Virological Response to Peginterferon and Ribavirin Therapy
Stephen A. Harrison et al.
HEPATOLOGY (2010)
Inhibition of Cell Migration and Cell Division Correlates with Distinct Effects of Microtubule Inhibiting Drugs
Hailing Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Hepatitis A and Hepatitis C Viruses: Divergent Infection Outcomes Marked by Similarities in Induction and Evasion of Interferon Responses
Lin Qu et al.
SEMINARS IN LIVER DISEASE (2010)
Hepatitis C virus hijacks host lipid metabolism
Gulam H. Syed et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
Microtubules and resistance to tubulin-binding agents
Maria Kavallaris
NATURE REVIEWS CANCER (2010)
Statins Potentiate the In Vitro Anti-Hepatitis C Virus Activity of Selective Hepatitis C Virus Inhibitors and Delay or Prevent Resistance Development
Leen Delang et al.
HEPATOLOGY (2009)
An Open Pilot Study Exploring the Efficacy of Fluvastatin, Pegylated Interferon and Ribavirin in Patients with Hepatitis C Virus Genotype 1b in High Viral Loads
Hitomi Sezaki et al.
INTERVIROLOGY (2009)
Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV coinfected patients
L. Milazzo et al.
JOURNAL OF VIRAL HEPATITIS (2009)
Fluvastatin inhibits hepatitis C replication in humans
Ted Bader et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
A Dynamic View of Hepatitis C Virus Replication Complexes
Benno Woelk et al.
JOURNAL OF VIROLOGY (2008)
Association of hepatitis C virus replication complexes with microtubules and actin filaments is dependent on the interaction of NS3 and NS5A
Chao-Kuen Lai et al.
JOURNAL OF VIROLOGY (2008)
Replication of hepatitis C virus
Darius Moradpour et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Different anti-HCV profiles of statins and their potential for combination therapy with interferon
Masanori Ikeda et al.
HEPATOLOGY (2006)
Effect of cell growth on hepatitis C virus (HCV) replication and a mechanism of cell confluence-based inhibition of HCV RNA and protein expression
HB Nelson et al.
JOURNAL OF VIROLOGY (2006)
Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA
CL Jopling et al.
SCIENCE (2005)
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
T Wakita et al.
NATURE MEDICINE (2005)
Identification of FBL2 as a geranylgeranylated required for hepatitis C cellular protein virus RNA replication
CF Wang et al.
MOLECULAR CELL (2005)
Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids
SB Kapadia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Update on statins: 2003
CJ Vaughan et al.
CIRCULATION (2004)
Microtubule-interacting drugs for cancer treatment
PM Checchi et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Cell-free replication of the hepatitis C virus subgenomic replicon
N Ali et al.
JOURNAL OF VIROLOGY (2002)
Effect of alpha interferon on the hepatitis C virus replicon
JT Guo et al.
JOURNAL OF VIROLOGY (2001)
分享论文
